Literature DB >> 939236

Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.

P Dombernowsky, N I Nissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 939236     DOI： 10.1016/0014-2964(76)90239-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

Review 1.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 2.  Current development of podophyllotoxins.

Authors:  R Canetta; P Hilgard; S Florentine; P Bedogni; L Lenaz
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 3.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

4.  Synergistic antitumor activity of vincristine and VP-16-213.

Authors:  D V Jackson; T R Long; T F Trahey; T M Morgan
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 5.  Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies.

Authors:  S C Remick; N Sedransk; R Haase; M Craffey; N Subramanian; A Dowlati; T Nazeer; C Ramnes; C Blanchard; D Mastrianni; L Balducci; J Horton; J C Ruckdeschel
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 6.  Cyclophosphamide and etoposide for non-small cell and small cell lung cancer.

Authors:  S M Grunberg
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 7.  Podophyllotoxin derivative VP 16-213.

Authors:  A M Arnold
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].

Authors:  H J Schmoll; N Niederle; W Achterrath
Journal:  Klin Wochenschr       Date:  1981-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.